Essential thrombocythemia (ET) “is really a disease that is considered benign,” Dr. Lucia Masarova, assistant professor in the department of leukemia at MD Anderson Cancer Center in Houston, stated ...
MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often occurring at atypical sites. Genetic analysis shows JAK2 mutations are more common ...